Novel Treatment Approaches with mAbs Targeting Amyloid Depos

A panel of expert oncologists explore novel therapies using monoclonal antibodies designed to target amyloid deposit, highlighting key data from the VITAL study.

Related Keywords

, Transforming Outcomes , Precision Medicine , Targeted Therapies , Treatment Approaches , Abs Targeting Amyloid Deposits , Light Chain Amyloidosis , Al Amyloidosis , Andromeda , Daratumumab , Vital , Pronto , Affirm Al , Nexicart 1 , Amyloid Deposits , Cd 38 Directed Monoclonal Antibodies , Cardiac Involvement , Mayo Cardiac Staging , Stem Cell Transplant , Remission , Duration Of Therapy , Diagnosis , Unmet Needs , Managing Al Amyloidosis , Treating Al Amyloidosis , Nxc 201 , Cart Therapy , Amyloidosis Diagnosis , Prognosis , Mortality ,